Efficacy of Risk-Reduction Counseling to Prevent Human Immunodeficiency Virus and Sexually Transmitted Diseases: A Randomized Controlled Trial

Clicks: 321
ID: 115556
1998
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #68 of 149 articles by views in JAMA

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 149 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Context.— The efficacy of counseling to prevent infection with the human immunodeficiency virus (HIV) and other sexually transmitted diseases (STDs) has not been definitively shown. Objective.— To compare the effects of 2 interactive HIV/STD counseling interventions with didactic prevention messages typical of current practice. Design.— Multicenter randomized controlled trial (Project...
Reference Key
kamb1998jamaefficacy Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Mary L. Kamb;Martin Fishbein;John M. Douglas, Jr;Fen Rhodes;Judy Rogers;Gail Bolan;Jonathan Zenilman;Tamara Hoxworth;C. Kevin Malotte;Michael Iatesta;Charlotte Kent;Andrew Lentz;Sandra Graziano;Robert H. Byers;Thomas A. Peterman;for the Project RESPECT Study Group;
Journal JAMA
Year 1998
DOI
DOI not found
URL
http://dx.doi.org/10.1001/jama.280.13.1161
Keywords
sexually transmitted diseases counseling hiv gonorrhea syphilis risk reduction follow-up visit arm

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.